168 related articles for article (PubMed ID: 6281621)
1. Preparation and properties of human C1 inhibitor.
Sim RB; Reboul A
Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
[No Abstract] [Full Text] [Related]
2. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s.
Nilsson T; Wiman B
Eur J Biochem; 1983 Jan; 129(3):663-7. PubMed ID: 6297891
[No Abstract] [Full Text] [Related]
4. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
5. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
6. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
Bauer J; Valet G
Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
[TBL] [Abstract][Full Text] [Related]
7. A molecular mechanism for the activation of the first component of complement by immune complexes.
Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
[TBL] [Abstract][Full Text] [Related]
8. Structure and activation of C1: current concepts.
Colomb MG; Arlaud GJ; Villiers CL
Complement; 1984; 1(2):69-80. PubMed ID: 6100485
[No Abstract] [Full Text] [Related]
9. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
Sim RB; Arlaud GJ; Colomb MG
Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
[No Abstract] [Full Text] [Related]
10. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
11. Structural features of the first component of human complement, C1, as revealed by surface iodination.
Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
[TBL] [Abstract][Full Text] [Related]
12. Activation of the first component of complement.
Schumaker VN; Zavodszky P; Poon PH
Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
[No Abstract] [Full Text] [Related]
13. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
14. C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease.
Loos M; Colomb M
Behring Inst Mitt; 1993 Dec; (93):1-5. PubMed ID: 8172555
[No Abstract] [Full Text] [Related]
15. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of C1 and concentration dependence of its activation kinetics.
Kilchherr E; Fuchs H; Tschopp J; Engel J
Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
Bensa JC; Reboul A; Colomb MG
Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
[TBL] [Abstract][Full Text] [Related]
18. Surfactant protein A regulates complement activation.
Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
[TBL] [Abstract][Full Text] [Related]
19. Atypical hypocomplementemic vasculitis syndrome in a child.
Waldo FB; Leist PA; Strife CF; Forristal J; West CD
J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
Jackson J; Sim RB; Whaley K; Feighery C
J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
